• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed

    2/10/21 4:45:29 PM ET
    $DNMR
    Major Chemicals
    Industrials
    Get the next $DNMR alert in real time by email
    SC 13G/A 1 DNMR_13GA1.htm SCHEDULE 13G

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    SCHEDULE 13G
    Under the Securities Exchange Act of 1934

    (AMENDMENT NO. 1)

    DANIMER SCIENTIFIC, INC.
    (formerly Live Oak Acquisition Corp.)
    (Name of Issuer)

    CLASS A COMMON STOCK, PAR VALUE $0.0001 PER SHARE
    (Title of Class of Securities)

    236272100
    (CUSIP Number)

    DECEMBER 31, 2020
    (Date of event which requires filing of this statement)

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

         o Rule 13d-1(b)

         þ Rule 13d-1(c)

         o Rule 13d-1(d)

    * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the notes).



                         
    CUSIP No.
     
    236272100

    SCHEDULE 13G

    Page  
    2
      of   
    15

    1
     NAMES OF REPORTING PERSONS
     
     Integrated Core Strategies (US) LLC
    2
     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
     (a)   o
     (b)   þ
    3
     SEC USE ONLY
    4
     CITIZENSHIP OR PLACE OF ORGANIZATION

     Delaware
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
    5
     SOLE VOTING POWER

     -0-
    6
     SHARED VOTING POWER

     10,500 (See Item 4(a))
     
    7
     SOLE DISPOSITIVE POWER

     -0-
     
    8
     SHARED DISPOSITIVE POWER

     10,500 (See Item 4(a))
    9
     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     10,500 (See Item 4(a))
    10  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     o
    11
     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     0.0%
    12 TYPE OF REPORTING PERSON

     OO


                         
    CUSIP No.
     
    236272100

    SCHEDULE 13G

    Page  
    3
      of   
    15

    1
     NAMES OF REPORTING PERSONS
     
     Riverview Group LLC
    2
     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
     (a)   o
     (b)   þ
    3
     SEC USE ONLY
    4
     CITIZENSHIP OR PLACE OF ORGANIZATION

     Delaware
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
    5
     SOLE VOTING POWER

     -0-
    6
     SHARED VOTING POWER

     -0- (See Item 4(a))
     
    7
     SOLE DISPOSITIVE POWER

     -0-
     
    8
     SHARED DISPOSITIVE POWER

     -0- (See Item 4(a))
     
    9
     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     -0- (See Item 4(a))
    10  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     o
    11
     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     0.0%
    12 TYPE OF REPORTING PERSON

     
    OO


                         
    CUSIP No.
     
    236272100

    SCHEDULE 13G

    Page  
    4
      of   
    15

    1
     NAMES OF REPORTING PERSONS
     
     ICS Opportunities, Ltd.
    2
     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
     (a)   o
     (b)   þ
    3
     SEC USE ONLY
    4
     CITIZENSHIP OR PLACE OF ORGANIZATION

     Cayman Islands
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
    5
     SOLE VOTING POWER

     -0-
    6
     SHARED VOTING POWER

     313,065 (See Item 4(a))
     
    7
     SOLE DISPOSITIVE POWER

     -0-
     
    8
     SHARED DISPOSITIVE POWER

     313,065 (See Item 4(a))
     
    9
     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     313,065 (See Item 4(a))
    10  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     o
    11
     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     0.4%
    12 TYPE OF REPORTING PERSON

     
    CO


                         
    CUSIP No.
     
    236272100

    SCHEDULE 13G

    Page  
    5
      of   
    15

    1
     NAMES OF REPORTING PERSONS
     
     Millennium International Management LP
    2
     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
     (a)   o
     (b)   þ
    3
     SEC USE ONLY
    4
     CITIZENSHIP OR PLACE OF ORGANIZATION

     Delaware
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
    5
     SOLE VOTING POWER

     -0-
    6
     SHARED VOTING POWER

     313,065 (See Item 4(a))
     
    7
     SOLE DISPOSITIVE POWER

     -0-
     
    8
     SHARED DISPOSITIVE POWER

     313,065 (See Item 4(a))
     
    9
     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     313,065 (See Item 4(a))
    10  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     o
    11
     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     0.4%
    12 TYPE OF REPORTING PERSON

     
    PN


                         
    CUSIP No.
     
    236272100

    SCHEDULE 13G

    Page  
    6
      of   
    15

    1
     NAMES OF REPORTING PERSONS
     
     Millennium Management LLC
    2
     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
     (a)   o
     (b)   þ
    3
     SEC USE ONLY
    4
     CITIZENSHIP OR PLACE OF ORGANIZATION

     Delaware
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
    5
     SOLE VOTING POWER

     -0-
    6
     SHARED VOTING POWER

     323,565 (See Item 4(a))
     
    7
     SOLE DISPOSITIVE POWER

     -0-
     
    8
     SHARED DISPOSITIVE POWER

     323,565 (See Item 4(a))
     
    9
     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     323,565 (See Item 4(a))
    10  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     o
    11
     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     0.4%
    12 TYPE OF REPORTING PERSON

     
    OO


                         
    CUSIP No.
     
    236272100

    SCHEDULE 13G

    Page  
    7
      of   
    15

    1
     NAMES OF REPORTING PERSONS
     
     Millennium Group Management LLC
    2
     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
     (a)   o
     (b)   þ
    3
     SEC USE ONLY
    4
     CITIZENSHIP OR PLACE OF ORGANIZATION

     Delaware
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
    5
     SOLE VOTING POWER

     -0-
    6
     SHARED VOTING POWER

     323,565 (See Item 4(a))
     
    7
     SOLE DISPOSITIVE POWER

     -0-
     
    8
     SHARED DISPOSITIVE POWER

     323,565 (See Item 4(a))
     
    9
     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     323,565 (See Item 4(a))
    10  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     o
    11
     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     0.4%
    12 TYPE OF REPORTING PERSON

     
    OO


                         
    CUSIP No.
     
    236272100

    SCHEDULE 13G

    Page  
    8
      of   
    15

    1
     NAMES OF REPORTING PERSONS
     
     Israel A. Englander
    2
     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
     (a)   o
     (b)   þ
    3
     SEC USE ONLY
    4
     CITIZENSHIP OR PLACE OF ORGANIZATION

     United States
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
    5
     SOLE VOTING POWER

     -0-
    6
     SHARED VOTING POWER

     323,565 (See Item 4(a))
     
    7
     SOLE DISPOSITIVE POWER

     -0-
     
    8
     SHARED DISPOSITIVE POWER

     323,565 (See Item 4(a))
     
    9
     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     323,565 (See Item 4(a))
    10
     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     o
    11
     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     0.4%
    12
     TYPE OF REPORTING PERSON

     IN

                         
    CUSIP No.
     
    236272100

     SCHEDULE 13G

    Page  
    9
      of   
    15
     
    Item 1.    
     
    (a) Name of Issuer:
     
       
     
      Danimer Scientific, Inc., a Delaware corporation (the "Issuer").
     
       
     
    (b) Address of Issuer’s Principal Executive Offices:
     
       
     
     

    140 Industrial Boulevard
    Bainbridge, Georgia 39817

         
    Item 2.
    (a) Name of Person Filing:
     
    (b) Address of Principal Business Office:
     
    (c) Citizenship:
         
     
      Integrated Core Strategies (US) LLC
    c/o Millennium Management LLC
    666 Fifth Avenue
    New York, New York 10103
    Citizenship: Delaware
     
       
     
      Riverview Group LLC
    c/o Millennium Management LLC
    666 Fifth Avenue
    New York, New York 10103
    Citizenship: Delaware
     
       
     
      ICS Opportunities, Ltd.
    c/o Millennium International Management LP
    666 Fifth Avenue
    New York, New York 10103
    Citizenship: Cayman Islands
     
       
     
      Millennium International Management LP
    666 Fifth Avenue
    New York, New York 10103
    Citizenship: Delaware
     
       
     
      Millennium Management LLC
    666 Fifth Avenue
    New York, New York 10103
    Citizenship: Delaware
     
       
     
      Millennium Group Management LLC
    666 Fifth Avenue
    New York, New York 10103
    Citizenship: Delaware
     
       
     
      Israel A. Englander
    c/o Millennium Management LLC
    666 Fifth Avenue
    New York, New York 10103
    Citizenship: United States
     
       
      (d) Title of Class of Securities:
    Class A common stock, par value $0.0001 per share ("Class A Common Stock")
     
      (e) CUSIP Number:
         
        236272100


                         
    CUSIP No.
     
    236272100

    SCHEDULE 13G

    Page  
    10
      of   
    15

    Item 3.  If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b), check whether the person filing is a:

     
      (a)   o   Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
                 
     
      (b)   o   Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
                 
     
      (c)   o   Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
                 
     
      (d)   o   Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
                 
     
      (e)   o   An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
                 
     
      (f)   o    An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);

                         
    CUSIP No.
     
    236272100

     SCHEDULE 13G

    Page  
    11
      of   
    15
                 
     
      (g)   o   A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);
                 
     
      (h)   o   A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
                 
     
      (i)   o   A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
                 
     
      (j)   o   Group, in accordance with §240.13d-1(b)(1)(ii)(J).

    Item 4. Ownership

       Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

    (a) Amount Beneficially Owned:

       As of the close of business on December 31, 2020:

       i) Integrated Core Strategies (US) LLC, a Delaware limited liability company ("Integrated Core Strategies"), beneficially owned 10,500 shares of the Issuer’s Class A Common Stock;

       ii) Riverview Group LLC, a Delaware limited liability company, no longer beneficially owned any shares of the Issuer’s Class A Common Stock; and

       iii) ICS Opportunities, Ltd., an exempted company organized under the laws of the Cayman Islands ("ICS Opportunities"), beneficially owned 313,065 shares of the Issuer’s Class A Common Stock as a result of holding 13,065 shares of the Issuer’s Class A Common Stock and warrants to purchase 300,000 shares of the Issuer’s Class A Common Stock, which together with the shares of the Issuer’s Class A Common Stock beneficially owned by Integrated Core Strategies represented 323,565 shares of the Issuer’s Class A Common Stock or 0.4% of the Issuer’s Class A Common Stock outstanding.

       Millennium International Management LP, a Delaware limited partnership ("Millennium International Management"), is the investment manager to ICS Opportunities and may be deemed to have shared voting control and investment discretion over securities owned by ICS Opportunities.

       Millennium Management LLC, a Delaware limited liability company ("Millennium Management"), is the general partner of the managing member of Integrated Core Strategies and may be deemed to have shared voting control and investment discretion over securities owned by Integrated Core Strategies. Millennium Management is also the general partner of the 100% owner of ICS Opportunities and may also be deemed to have shared voting control and investment discretion over securities owned by ICS Opportunities.

       Millennium Group Management LLC, a Delaware limited liability company ("Millennium Group Management"), is the managing member of Millennium Management and may also be deemed to have shared voting control and investment discretion over securities owned by Integrated Core Strategies. Millennium Group Management is also the general partner of Millennium International Management and may also be deemed to have shared voting control and investment discretion over securities owned by ICS Opportunities.

       The managing member of Millennium Group Management is a trust of which Israel A. Englander, a United States citizen ("Mr. Englander"), currently serves as the sole voting trustee. Therefore, Mr. Englander may also be deemed to have shared voting control and investment discretion over securities owned by Integrated Core Strategies and ICS Opportunities.

       The foregoing should not be construed in and of itself as an admission by Millennium International Management, Millennium Management, Millennium Group Management or Mr. Englander as to beneficial ownership of the securities owned by Integrated Core Strategies or ICS Opportunities, as the case may be.

    (b) Percent of Class:   

       As of the close of business on December 31, 2020, Millennium Management, Millennium Group Management and Mr. Englander may be deemed to have beneficially owned 323,565 shares of the Issuer’s Class A Common Stock or 0.4% of the Issuer’s Class A Common Stock outstanding (see Item 4(a) above), which percentage was calculated based on 85,724,570 shares of the Issuer’s Class A Common Stock outstanding as of December 29, 2020, as reported in the Issuer’s Form 8-K filed on January 5, 2021.


                         
    CUSIP No.
     
    236272100

     SCHEDULE 13G

    Page  
    12
      of   
    15

     (c) Number of shares as to which such person has:

    (i) Sole power to vote or to direct the vote

       -0-

    (ii) Shared power to vote or to direct the vote

       323,565 (See Item 4(b))

     (iii) Sole power to dispose or to direct the disposition of

       -0-

    (iv) Shared power to dispose or to direct the disposition of

       323,565 (See Item 4(b))

    Item 5. Ownership of Five Percent or Less of a Class

       If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following þ.

    Item 6. Ownership of More than Five Percent on Behalf of Another Person.

        Not applicable.

    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.

        Not applicable.

    Item 8. Identification and Classification of Members of the Group

        See Exhibit I.

    Item 9. Notice of Dissolution of Group

        Not applicable.

    Item 10. Certification 

       By signing below each of the undersigned certifies that, to the best of its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.


                         
    CUSIP No.
     
    236272100

    SCHEDULE 13G

    Page  
    13
      of   
    15

    Exhibits:

    Exhibit I: Joint Filing Agreement, dated as of February 9, 2021, by and among Integrated Core Strategies (US) LLC, Riverview Group LLC, ICS Opportunities, Ltd., Millennium International Management LP, Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander.


                         
    CUSIP No.
     
    236272100

    SCHEDULE 13G

    Page  
    14
      of   
    15
                         
         

    SIGNATURE

                 

    After reasonable inquiry and to the best of its knowledge and belief, each of the undersigned certifies that the information with respect to it set forth in this statement is true, complete, and correct.

    Dated: February 9, 2021

    INTEGRATED CORE STRATEGIES (US) LLC

    By: Integrated Holding Group LP,
           its Managing Member

    By: Millennium Management LLC,
           its General Partner

    By: /s/ Gil Raviv

    Name: Gil Raviv
    Title:  Global General Counsel

     

    RIVERVIEW GROUP LLC

    By: Integrated Holding Group LP,
           its Managing Member

    By: Millennium Management LLC,
           its General Partner

    By: /s/ Gil Raviv

    Name: Gil Raviv
    Title:  Global General Counsel

     

    ICS OPPORTUNITIES, LTD.

    By: Millennium International Management LP,
           its Investment Manager

    By: /s/ Gil Raviv

    Name: Gil Raviv
    Title:  Global General Counsel

     

    MILLENNIUM INTERNATIONAL MANAGEMENT LP

    By: /s/Gil Raviv

    Name: Gil Raviv
    Title:  Global General Counsel

     

    MILLENNIUM MANAGEMENT LLC

    By: /s/Gil Raviv

    Name: Gil Raviv
    Title:  Global General Counsel

     

    MILLENNIUM GROUP MANAGEMENT LLC

    By: /s/Gil Raviv

    Name: Gil Raviv
    Title:  Global General Counsel

     

    /s/ Israel A. Englander

    Israel A. Englander



                         
    CUSIP No.
     
    236272100

    SCHEDULE 13G

    Page  
    15
      of   
    15
                         
          EXHIBIT I              
                         
          JOINT FILING AGREEMENT              

    This will confirm the agreement by and among the undersigned that the Schedule 13G filed with the Securities and Exchange Commission on or about the date hereof with respect to the beneficial ownership by the undersigned of the Class A Common Stock, par value $0.0001 per share, of Danimer Scientific, Inc., a Delaware corporation, will be filed on behalf of each of the persons and entities named below in accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.

    Dated: February 9, 2021

    INTEGRATED CORE STRATEGIES (US) LLC

    By: Integrated Holding Group LP,
           its Managing Member

    By: Millennium Management LLC,
           its General Partner

    By: /s/ Gil Raviv

    Name: Gil Raviv
    Title:  Global General Counsel

     

    RIVERVIEW GROUP LLC

    By: Integrated Holding Group LP,
           its Managing Member

    By: Millennium Management LLC,
           its General Partner

    By: /s/ Gil Raviv

    Name: Gil Raviv
    Title:  Global General Counsel

     

    ICS OPPORTUNITIES, LTD.

    By: Millennium International Management LP,
           its Investment Manager

    By: /s/ Gil Raviv

    Name: Gil Raviv
    Title:  Global General Counsel

     

    MILLENNIUM INTERNATIONAL MANAGEMENT LP

    By: /s/Gil Raviv

    Name: Gil Raviv
    Title:  Global General Counsel

     

    MILLENNIUM MANAGEMENT LLC

    By: /s/Gil Raviv

    Name: Gil Raviv
    Title:  Global General Counsel

     

    MILLENNIUM GROUP MANAGEMENT LLC

    By: /s/Gil Raviv

    Name: Gil Raviv
    Title:  Global General Counsel

     

    /s/ Israel A. Englander

    Israel A. Englander


    Get the next $DNMR alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $DNMR

    DatePrice TargetRatingAnalyst
    11/21/2024$40.00 → $5.50Hold
    TD Cowen
    11/20/2024$40.00 → $4.00Neutral → Underweight
    Piper Sandler
    8/13/2024$2.00 → $1.00Buy → Hold
    TD Cowen
    5/22/2024$1.30 → $0.80Buy → Hold
    Jefferies
    4/9/2024$3.50 → $1.25Overweight → Neutral
    Piper Sandler
    10/12/2022$4.50Overweight
    Piper Sandler
    9/23/2021$21.00Outperform
    Cowen
    More analyst ratings

    $DNMR
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Danimer Scientific Announces Common Stock Expected to Begin Trading Promptly on OTCQX Marketplace

      –Dividend warrants continue to trade on OTCQX marketplace under "DNMRW"– Danimer Scientific, Inc. (NYSE:DNMR) ("Danimer" or the "Company"), a leading next generation bioplastics company focused on the development and production of biodegradable materials, today announced that it received notice the New York Stock Exchange ("NYSE") suspended trading of its common stock on the NYSE effective immediately and started the process to delist its common stock from the NYSE. The start of the delisting process follows the NYSE's determination under Rule 802.01B of the NYSE Listed Company Manual that the Company did not meet the continued listing standard that requires listed companies to maintain a

      12/31/24 8:00:00 AM ET
      $DNMR
      Major Chemicals
      Industrials
    • Danimer Scientific Takes Action to Strengthen Capital Structure

      Announces Issuance of $11,250,000 Super Senior Secured Promissory Note Danimer Scientific, Inc. (NYSE:DNMR) ("Danimer" or the "Company"), a leading next generation bioplastics company focused on the development and production of biodegradable materials, today announced that the Company issued a super senior secured promissory note (the "Secured Loan") in an aggregate principal amount of $11,250,000 to certain lenders under its existing term loan financing agreement, as well as certain additional lenders. The Secured Loan provides for $11,250,000 gross proceeds, less fees and expenses. The Secured Loan has a two-year maturity and accrues interest at 15.0% per annum, which interest is payab

      12/17/24 4:15:00 PM ET
      $DNMR
      Major Chemicals
      Industrials
    • TerraNova Capital Equities announces three transactions totaling $45 Million

      NEW YORK, Nov. 20, 2024 /PRNewswire/ -- TerraNova Capital Equities, inc. (TerraNova), a leading financial advisory firm, is pleased to announce that its Structure Finance Group acted as sole advisor on three recent transactions: TerraNova Structured Finance Group acted as the sole advisor to Danimer Scientific, Inc. (NYSE:DNMR) on a $20 Million revolving credit facility. TerraNova is pleased to announce its role as the exclusive advisor to Danimer Scientific in securing a strategic ABL agreement with Mountain Ridge Capital.  This $20 million facility, collateralized by the Com

      11/20/24 10:30:00 AM ET
      $DNMR
      $INUV
      Major Chemicals
      Industrials
      Advertising
      Consumer Discretionary

    $DNMR
    SEC Filings

    See more
    • Danimer Scientific Inc. filed SEC Form 8-K: Bankruptcy or Receivership, Events That Accelerate or Increase a Direct Financial Obligation, Other Events, Financial Statements and Exhibits

      8-K - Danimer Scientific, Inc. (0001779020) (Filer)

      3/18/25 5:00:42 PM ET
      $DNMR
      Major Chemicals
      Industrials
    • Danimer Scientific Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

      8-K - Danimer Scientific, Inc. (0001779020) (Filer)

      2/28/25 5:00:09 PM ET
      $DNMR
      Major Chemicals
      Industrials
    • Amendment: SEC Form SCHEDULE 13G/A filed by Danimer Scientific Inc.

      SCHEDULE 13G/A - Danimer Scientific, Inc. (0001779020) (Subject)

      2/14/25 5:41:32 PM ET
      $DNMR
      Major Chemicals
      Industrials

    $DNMR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Financial Officer Hajost Michael A converted options into 859 shares and covered exercise/tax liability with 301 shares, increasing direct ownership by 31% to 2,334 units (SEC Form 4)

      4 - Danimer Scientific, Inc. (0001779020) (Issuer)

      2/10/25 4:30:05 PM ET
      $DNMR
      Major Chemicals
      Industrials
    • Director Moody David Jesse converted options into 646 shares (SEC Form 4)

      4 - Danimer Scientific, Inc. (0001779020) (Issuer)

      1/21/25 4:30:10 PM ET
      $DNMR
      Major Chemicals
      Industrials
    • SEC Form 4 filed by Director Croskrey Stephen

      4 - Danimer Scientific, Inc. (0001779020) (Issuer)

      1/3/25 4:05:07 PM ET
      $DNMR
      Major Chemicals
      Industrials

    $DNMR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • TD Cowen reiterated coverage on Danimer Scientific with a new price target

      TD Cowen reiterated coverage of Danimer Scientific with a rating of Hold and set a new price target of $5.50 from $40.00 previously

      11/21/24 8:09:13 AM ET
      $DNMR
      Major Chemicals
      Industrials
    • Danimer Scientific downgraded by Piper Sandler with a new price target

      Piper Sandler downgraded Danimer Scientific from Neutral to Underweight and set a new price target of $4.00 from $40.00 previously

      11/20/24 9:49:17 AM ET
      $DNMR
      Major Chemicals
      Industrials
    • Danimer Scientific downgraded by TD Cowen with a new price target

      TD Cowen downgraded Danimer Scientific from Buy to Hold and set a new price target of $1.00 from $2.00 previously

      8/13/24 7:29:01 AM ET
      $DNMR
      Major Chemicals
      Industrials

    $DNMR
    Leadership Updates

    Live Leadership Updates

    See more
    • Danimer Scientific Announces New Directors

      Dr. David Moody and Richard Altice to Join the Danimer Board Danimer Scientific, Inc. (NYSE:DNMR) ("Danimer" or the "Company"), a leading, next-generation bioplastics company focused on the production of biodegradable materials, is pleased to announce that Dr. David Moody and Mr. Richard Altice have been appointed as members of Danimer's Board of Directors. Dr. Moody's appointment is effective immediately, and Mr. Altice's appointment is effective as of April 15, 2024. Dr. David J. Moody currently is a member of the Board of Directors of Jadex Inc., a US-based manufacturing and material science company utilizing innovation and technology to develop sustainable products that serve the me

      1/18/24 4:30:00 PM ET
      $DNMR
      Major Chemicals
      Industrials
    • Danimer Scientific Appoints Stephen Martin as Chief Legal Officer and Corporate Secretary

      Martin, a Duke University graduate and former Air Force officer, brings experience managing the legal affairs of publicly traded companies Danimer Scientific, Inc. (NYSE:DNMR) ("Danimer" or the "Company"), a leading next-generation bioplastics company focused on the development and production of biodegradable materials, today announced it has appointed Stephen Martin as Chief Legal Officer and Corporate Secretary. In this role, Martin will manage a wide range of legal matters across the company as Danimer continues to expand its manufacturing capacity to meet demand in the fast-growing bioplastics market. Martin joins Danimer from Kaman Distribution Group, a leading national distributor o

      9/20/22 8:30:00 AM ET
      $DNMR
      Major Chemicals
      Industrials
    • Danimer Scientific Appoints Anthony Austin as Chief Human Resource Officer

      Austin brings more than 30 years of human resources leadership experience with PepsiCo, Delta Air Lines, Winn-Dixie and others Danimer Scientific, Inc. (NYSE:DNMR) ("Danimer" or the "Company"), a leading next-generation bioplastics company focused on the development and production of biodegradable materials, today announced it has appointed Anthony Austin as Chief Human Resource Officer. In this role, Austin will focus on building best-in-class HR processes to strategically support the Company's growth as it continues to expand its manufacturing capacity. Austin joins Danimer from Bedrock Manufacturing Co., the parent company of Shinola, a luxury watch, leather and jewelry manufacturer an

      4/20/22 8:00:00 AM ET
      $DNMR
      Major Chemicals
      Industrials

    $DNMR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Hendrix Richard J bought $93,395 worth of shares (100,000 units at $0.93) (SEC Form 4)

      4 - Danimer Scientific, Inc. (0001779020) (Issuer)

      11/28/23 5:35:32 PM ET
      $DNMR
      Major Chemicals
      Industrials

    $DNMR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Danimer Scientific Inc.

      SC 13G - Danimer Scientific, Inc. (0001779020) (Subject)

      11/14/24 3:28:09 PM ET
      $DNMR
      Major Chemicals
      Industrials
    • Amendment: SEC Form SC 13G/A filed by Danimer Scientific Inc.

      SC 13G/A - Danimer Scientific, Inc. (0001779020) (Subject)

      7/8/24 4:36:39 PM ET
      $DNMR
      Major Chemicals
      Industrials
    • SEC Form SC 13G/A filed by Danimer Scientific Inc. (Amendment)

      SC 13G/A - Danimer Scientific, Inc. (0001779020) (Subject)

      1/29/24 5:25:54 PM ET
      $DNMR
      Major Chemicals
      Industrials

    $DNMR
    Financials

    Live finance-specific insights

    See more
    • Danimer Scientific Announces Common Stock Expected to Begin Trading Promptly on OTCQX Marketplace

      –Dividend warrants continue to trade on OTCQX marketplace under "DNMRW"– Danimer Scientific, Inc. (NYSE:DNMR) ("Danimer" or the "Company"), a leading next generation bioplastics company focused on the development and production of biodegradable materials, today announced that it received notice the New York Stock Exchange ("NYSE") suspended trading of its common stock on the NYSE effective immediately and started the process to delist its common stock from the NYSE. The start of the delisting process follows the NYSE's determination under Rule 802.01B of the NYSE Listed Company Manual that the Company did not meet the continued listing standard that requires listed companies to maintain a

      12/31/24 8:00:00 AM ET
      $DNMR
      Major Chemicals
      Industrials
    • Danimer Scientific Announces Third Quarter 2024 Results

      --Additional Resin Orders and Deliveries Continue to Support 20-Million Pound Cutlery Award –- -- 100% Compostable Skittles® Bag Made with Nodax® PHA Featured at NFL Game -- Danimer Scientific, Inc. (NYSE:DNMR) ("Danimer" or the "Company"), a leading next generation bioplastics company focused on the development and production of biodegradable materials, announced today financial results for its third quarter ended September 30, 2024. Richard N. Altice, Interim Chief Executive Officer of Danimer, commented, "We completed the third quarter in line with our expectations considering the temporary impact of Starbucks' reapportionment of their Nodax-based straw business between our convert

      11/19/24 8:30:00 AM ET
      $DNMR
      Major Chemicals
      Industrials
    • Danimer Scientific Announces Release Date for Third Quarter 2024 Results

      Danimer Scientific, Inc. (NYSE:DNMR) ("Danimer" or the "Company"), a leading, next-generation bioplastics company focused on the development and production of biodegradable materials, announced today that the Company will release its third quarter 2024 financial results before the market opens on Tuesday, November 19, 2024. A webcast and conference call will be held that same day at 10:00 a.m. Eastern Time to review the Company's third quarter results. The webcast of the conference will be accessible on the Investor Relations section of the Company's website at https://ir.danimerscientific.com. For those unable to access the webcast, the conference call will be accessible domestically o

      11/14/24 9:00:00 AM ET
      $DNMR
      Major Chemicals
      Industrials